Brereton CJ, et al. - Researchers investigated the safety and efficacy of gentamicin, an aminoglycoside with potent bactericidal activity, for empiric Gram-negative cover of severe community acquired pneumonia (CAP) admitted to intensive care unit (ICU). Findings suggested that in severe CAP admitted to ICU, gentamicin was safe and had similar outcomes to alternative Gram-negative antimicrobial regimens for empiric cover.